Systemic Sclerosis in a Preschool-Aged Patient: An Unusually Early Presentation of an Autoimmune Disease
Resumen
Introduction: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by skin fibrosis, vascular alterations, and specific autoantibodies. Onset during childhood is uncommon, and presentation at preschool age is exceptional. Case report: We describe an 8-year-old female presenting with a progressive indurated plaque on the left leg, refractory to topical treatments. Laboratory tests revealed positive antinuclear antibodies (ANA) and anti-topoisomerase I (Scl-70). Skin biopsy demonstrated epidermal atrophy and dermal sclerosis consistent with scleroderma. Nailfold capillaroscopy showed a scleroderma pattern, while chest CT, pulmonary function tests, and echocardiography revealed no visceral involvement. A diagnosis of juvenile systemic sclerosis was established. Methotrexate therapy was initiated, along with multidisciplinary follow-up, leading to clinical stabilization at six months. Discussion: Pediatric SSc accounts for less than 5% of all cases, with localized morphea being the most common subtype. Systemic disease at preschool age is exceedingly rare and poses diagnostic challenges. Capillaroscopy and systemic screening are essential for assessing progression risk. Methotrexate is considered first-line therapy in children, although long-term follow-up is mandatory to detect cardiopulmonary complications. Conclusions: This case contributes to the international literature by documenting an unusual presentation of SSc in preschool age, highlighting the importance of early diagnosis, immunomodulatory therapy, and multidisciplinary management.
Descargas
Citas
Castañeda NG, Rubio ER, Emperiale V, Hajkhan AM. Esclerosis sistémica. Medicine (Madrid). 2021;13(31):1769–78. doi:10.1016/j.med.2021.04.004
Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–99. doi:10.1016/S0140-6736(17)30933-9
Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2017;2(3):137–52. doi:10.5301/jsrd.5000249
Rodríguez-Pintó I, Simeón-Aznar CP, et al. Epidemiology of systemic sclerosis: a systematic review of the literature. Clin Epidemiol. 2016;8:61–72. doi:10.2147/CLEP.S99680
Elhai M, Avouac J, Allanore Y. Systemic sclerosis in adults and children: clinical manifestations and diagnosis. Rheumatology (Oxford). 2020;59(Suppl 5):v19–29. doi:10.1093/rheumatology/keaa573
Beukelman T, Xie F, Foeldvari I. Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States. Journal of Scleroderma and Related Disorders. 2018;3(2):189–190. doi:10.1177/2397198318763701
Martini G, Foeldvari I, Russo R, et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum. 2006;54(12):3971–8. doi:10.1002/art.22179
Tan HC, Poh CK, Cai Y, Wang W. Anti-fibrosis effect of BMP-7 peptide functionalization on cobalt chromium alloy. J Orthop Res. 2013 Jun;31(6):983-90. doi:10.1002/jor.22313. PMID:23456668.
Foeldvari I, Torok KS. Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points. Best Pract Res Clin Rheumatol. 2021;35(3):101688. doi:10.1016/j.berh.2021.101688. PMID:33896752.
Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002. doi:10.1038/nrdp.2015.2
Elhai M, Meune C, Boubaya M, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76(11):1897–905. doi:10.1136/annrheumdis-2017-211448
Zulian F, Woo P, Athreya BH, et al. The Pediatric Rheumatology European Society/American College of Rheumatology/European League Against Rheumatism classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 2007;57(2):203–12. doi:10.1002/art.22551
Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52(9):2873–81. doi:10.1002/art.21265
Li SC, Torok KS, Pope E, et al. Development of consensus treatment plans for juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012;64(8):1175–85. doi:10.1002/acr.21677
Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol. 2010;6(10):578–587. doi:10.1038/nrrheum.2010.104
Herrick AL, Ennis H, Bhushan M, et al. Nailfold capillaroscopy in children with connective tissue disease: a prospective multicentre study. Arthritis Care & Research (Hoboken). 2013;65(9):1423–1431. doi:10.1002/acr.22007.
Zulian F, Cuffaro G, Sperotto F. Methotrexate in juvenile localized scleroderma: state of the art. Clinical and Experimental Rheumatology. 2015;33(4 Suppl 91):S109–S112. PMID:26314405.
Pope JE, Denton CP. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023;19(4):212–226. doi:10.1038/s41584-023-00909-5.
Foeldvari I, Constantin T, Zulian F, et al. Tocilizumab in juvenile systemic sclerosis: first report from the international juvenile scleroderma cohort. Rheumatology (Oxford). 2020;59(2):435–439. doi:10.1093/rheumatology/kez310.
Foeldvari I, Martini G, Russo R, Cuttica R, Pilkington C, Katsicas MM, et al. Survival and disease progression in juvenile systemic sclerosis: a multinational, multicenter cohort study. Arthritis & Rheumatology. 2020;72(11):1915–1924. doi:10.1002/art.41449.
Foeldvari I, Wulffraat N, Kasapcopur O, et al. The Juvenile Systemic Sclerosis Inception Cohort (jSSc): an international inception cohort study. Pediatr Rheumatol Online J. 2019;17(1):85. doi:10.1186/s12969-019-0390-5
Sánchez Sánchez, J. E., & Fernández Paradas, A. R. (2025). Análisis de Estrategias Didácticas Implementadas para el Desarrollo de Competencias Textuales en Estudiantes de Secundaria. Ciencia Y Reflexión, 4(2), 2384–2411. https://doi.org/10.70747/cr.v4i2.497
Castro Valdivieso, C., & Rivera Cid, R. I. (2025). Exploring EFL Instructors’ Strategies and challenges for learners Autonomy and Self-regulation in blended learning contexts in Chile. Ciencia Y Reflexión, 4(2), 2468–2491. https://doi.org/10.70747/cr.v4i2.419
Derechos de autor 2025 Melissa Carrillo Hernández , Braulio Esteban López Reyes, Karime Giselle Sandoval Enriquez, Daniela Nicolle Gómez Narváez, Gloria Jimena Coello Uribe

Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.